The Korea Bioimpedance Sensor Market is estimated to witness a rise in revenue from US$ 187.8 Mn in 2021 to US$ 288.4 Mn by 2027. The market is registering a CAGR of 7.4% during the forecast period 2022-2027. In terms of volume, the market is anticipated to register a CAGR of 6.4% over the forecast period. 

Bioimpedance devices are non-invasive, low-cost, portable, and user-friendly, and are used for the detection of edema, diagnosis of skin-related diseases, detection of cancerous tissues, brain and pulmonary function monitoring and impedance cardiography, and pneumography. Bioimpedance sensors technology is becoming the basis of novel and noninvasive medical diagnostic devices. On a smaller scale, it is used for measuring, analyzing, and imaging individual cells, cell cultures, and suspensions, as well as in electroporation studies. Moreover, bio-impedance sensors require higher power than most other bio-signal acquisition systems due to the need for high-frequency current and voltage management. 

Bioimpedance has the potential to play an important role in wearable devices, because of its relative reliability, electrode-based sensing principle, and its broad range of applications. In addition, bioimpedance techniques are also the foundation of various laboratory instruments for cell culture monitoring and cell mechanical properties research based on population, motility, viability, and others. The rising prevalence of chronic conditions such as diabetes and growing awareness among patients about health is the prime factors that propel the market growth.

Market Dynamics

The major factor responsible for the growth of the Korea bioimpedance sensor market includes the surging incidence of chronic diseases across the country and increasing advancements in life science and healthcare instrumentation. The rising prevalence of chronic disease and robust growth of the geriatric population with ailments that require quick treatments stimulate the demand for bioimpedance sensors. Bioimpedance is a flexible sensing technology that can be utilized for various clinical and lifestyle applications, including body fluid monitoring, gesture monitoring, and hemodynamic parameter monitoring. Moreover, the availability of high-performance health monitoring devices that are integrated with efficient bioimpedance sensors further boosts the bioimpedance sensor market. Furthermore, high bioimpedance sensor adoption in wearables devices creates a significant growth opportunity for the bioimpedance sensor market. 

Advances in electronics and instrumentation technology and novel textile materials and textile-electronic integration techniques encourage the development and implementation of sensor-based garments for wearable biomedical monitoring systems. However, less availability of miniaturized instrumentation, novel models, and algorithms will restrain the growth of the adoption of bioimpedance sensors across the Korea market. Also, the lack of a suitable electrode system for wearable applications is a barrier to the development of portable bioimpedance devices. 

Report Summary

The study of the Korea Bioimpedance Sensor Market considers various market determinants, industry value chain analysis, and competitor analysis of the market. The report discusses the analysis of the bioimpedance sensor industry for the period 2017-2027, where the base year is 2021 and the forecast period is 2022-2027. The report provides a detailed analysis of the Korea Bioimpedance Sensor Market across 7 Chapters and 46 pages. The report includes data presentation across 13 tables and 9 statistical figures. 

The subsequent section provides details of the market analysis based on different segments such as type, application, and country. The report includes a detailed study of the value chain of the industry. It includes suppliers, manufacturers, distributors, and end-users. The bioimpedance sensor market majorly follows the direct channel of marketing because they directly provide sensors to the customers. The basic channel flow covers the bioimpedance sensor process right from product conception to product development and consumption. The report also covers extensively the key competitors in the market for Korea bioimpedance sensor. 

Key Takeaways from the Korea Bioimpedance Sensor Market Report

• Based on type, the contact segment holds the largest share in the Korea bioimpedance sensors market in 2021 as it represents an accurate result output. Whereas the non-contact segment is anticipated to grow at the highest CAGR of 8.0% during the forecast period as there is no need for direct contact between the resonator and the body.
• On the basis of application, the medical use segment dominated the Korea bioimpedance sensor market in 2021. Due to the rapid advancements in the field of tissue engineering, it needs the deployment of real-time, non-invasive, and non-destructive monitoring technologies for assessing the viability and properties of cell cultures. Whereas the personal fitness tracking segment is anticipated to project the highest CAGR during the forecast period owing to the increasing number of fitness clubs and wellness centres and the growing awareness about health and fitness across the country. 

Company Profile 

• OMRON Corporate company was established in 1933 and offers automation, healthcare, and other related products and services. The company operates in the healthcare, social system, industrial automation, mechanical components, and business segments. It has various operational units in Korea, such as the industrial automation unit-OMRON Electronics Korea Co., Ltd. and Healthcare-Omron Healthcare Korea Co., Ltd. among others. In 2020, Omron Corporate recorded a revenue of US$ 5,788.3 Million. 
• Analog Devices, Inc. operates in designing, manufacturing, and marketing a broad portfolio of high-performance analog, mixed-signal, and Digital Signal Processing (DSP) Integrated Circuits (ICs) used in virtually all types of electronic equipment. Moreover, the company has various subsidiaries such as Linear Technology, Linear Technology GmbH, Linear Semiconductor Sdn Bhd, and others. 
• Maxim Integrated is a US-based company, and it is now a part of Analog Devices, Inc. The company operates in the healthcare, automotive, communications & data center, consumer, and industrial markets business segments. The company operates in South Korea, China, India, the US, the UK, and other countries across the globe. Moreover, in 2021, the company recorded a revenue of US$ 2,632.5 Million. 

Competitive Landscape

The key players in the Korea Bioimpedance Sensor Market are Omron Corporate, Maxim Integrated, Texas Instruments Incorporated, Analog Devices, Inc. and Baxter International Inc. among others. Through extensive research, it is found that big players have adopted various competitive strategies such as mergers & acquisitions in order to have a grip of an emerging market. Furthermore, leading companies are expanding their geographical boundaries by acquiring small brands and domestic companies.

Segmentation Overview 

Korea Bioimpedance Sensor Market is segmented based on type and application. The industry trends in the bioimpedance sensor market are sub-divided into different categories in order to get a holistic view of the Korea marketplace.

Following are the different segments of the Korea Bioimpedance Sensor Market:

By Type segment of the Korea Bioimpedance Sensor Market is sub-segmented into:

• Contact Type
• Non-Contact Type

By Application segment of the Korea Bioimpedance Sensor Market is sub-segmented into:

• Personal Fitness Tracking
• Medical Use
• Others